Literature DB >> 20031716

Impact of NAD(P)H oxidase-derived reactive oxygen species on coronary arterial remodeling: a comparative intravascular ultrasound and histochemical analysis of atherosclerotic lesions.

Mitsuyasu Terashima1, Yoshitaka Ohashi, Hiroshi Azumi, Kazunori Otsui, Hideaki Kaneda, Kojiro Awano, Seiichi Kobayashi, Tomoyuki Honjo, Takahiko Suzuki, Kazumi Maeda, Mitsuhiro Yokoyama, Nobutaka Inoue.   

Abstract

BACKGROUND: Coronary arterial remodeling, which is a response to the growth of atherosclerotic plaques, is associated with plaque vulnerability. Oxidative stress induced by reactive oxygen species (ROS) via NAD(P)H oxidase in the vasculature also plays a crucial role in the pathogenesis of atherosclerosis-based cardiovascular disease. In this study, the relationship between coronary arterial remodeling and ROS generation was examined by comparing preinterventional intravascular ultrasound findings of atherosclerotic lesions to the histochemical findings of corresponding specimens obtained by directional coronary atherectomy. METHODS AND
RESULTS: Predirectional coronary atherectomy intravascular ultrasound images of 49 patients were analyzed. The remodeling index was calculated by dividing the target-lesion external elastic membrane cross-sectional area by the reference-segment external elastic membrane cross-sectional area. Expansive remodeling was defined as a remodeling index of >1.0. ROS generation and NAD(P)H oxidase p22(phox) expression in directional coronary atherectomy specimens were evaluated using the dihydroethidium staining method and immunohistochemistry as the ratio of the positive area to the total surface area in each specimen, respectively. ROS generation and p22(phox) expression were significantly greater in lesions with expansive remodeling than in lesions without remodeling (0.18+/-0.12 versus 0.03+/-0.02, P<0.0001, 0.10+/-0.08 versus 0.04+/-0.05, P=0.0039, respectively). Both ROS generation and p22(phox) expression significantly correlated with the intravascular ultrasound-derived remodeling index (r=0.77, P<0.0001, r=0.53, P<0.0001, respectively).
CONCLUSIONS: Simultaneous examination with intravascular ultrasound and immunohistochemistry analyses suggests that NAD(P)H oxidase-derived ROS is related to the coronary arterial remodeling process associated with plaque vulnerability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031716     DOI: 10.1161/CIRCINTERVENTIONS.108.799502

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  6 in total

Review 1.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

Review 2.  Oxidative stress, NADPH oxidases, and arteries.

Authors:  Qi-An Sun; Marschall S Runge; Nageswara R Madamanchi
Journal:  Hamostaseologie       Date:  2015-02-04       Impact factor: 1.778

3.  Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  Surgery       Date:  2012-05-08       Impact factor: 3.982

4.  Smooth muscle specific overexpression of p22phox potentiates carotid artery wall thickening in response to injury.

Authors:  Michael R Manogue; Justin R Bennett; Drury S Holland; Chung-Sik Choi; Douglas A Drake; Mark S Taylor; David S Weber
Journal:  Oxid Med Cell Longev       Date:  2015-04-05       Impact factor: 6.543

5.  Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5).

Authors:  Hope K A Gole; Darla L Tharp; Douglas K Bowles
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis.

Authors:  Miguel Romero; Elvira Leon-Gomez; Irina Lobysheva; Géraldine Rath; Jean-Michel Dogné; Olivier Feron; Chantal Dessy
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.